Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
12
Bearish filings
488
Named actors
35
Disclosed $ (bull / bear)
$1.1B + 1 of unknown size / $940.7M + 12 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $2.5M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $317K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $4.2M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $1.5M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $2.4M | SEC ↗ |
475+ more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only — a dense name; figures cover the most recent 500. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $234K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $753K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $1.1M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $239K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $118K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $111K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $278K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $117K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $437K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $1.6M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $2.5M | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $569K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $816K | SEC ↗ |
| 2026-10-15 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | sold | $315K | SEC ↗ |
| 2026-10-15 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MATTHEW RABINOWITZ | filed notice to sell | $19.7M | SEC ↗ |
| 2026-10-07 | EXECUTIVE CHAIRMAN Rabinowitz Matthew | gifted | — | SEC ↗ |
| 2026-10-01 | CEO AND PRESIDENT Chapman Steven Leonard | sold | $526K | SEC ↗ |
| 2026-10-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) SOLOMON MOSHKEVICH | filed notice to sell | $1.2M | SEC ↗ |
| 2026-10-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEVEN L CHAPMAN | filed notice to sell | $526K | SEC ↗ |
| 2026-10-01 | PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon | sold | $82K | SEC ↗ |